At the University of New Haven, the health and safety of all members of our community remain our top priority. We have reimagined life at the University to help deliver high-quality education in as safe an environment as possible.
This website provides updated information about our response to the pandemic and our ongoing efforts to prevent the spread of COVID-19, and is being continually updated throughout the Spring 2021 semester.
With widespread availability of several highly effective COVID-19 vaccines, University of New Haven leaders have a high degree of confidence the University will be able to return to many of its pre-pandemic norms in terms of class formats, student life, and other staples of the Charger experience.
Professor and Her Students May Have Found a Cure for Lyme Disease
Could a common sweetener that's already in the kitchen cupboards in many American homes — stevia — prove to be an effective treatment for a disease as debilitating and persistent as Lyme disease?
July 07, 2017
It's too early to say that for sure, but research by Eva Sapi, a University of New Haven professor of cellular and molecular biology, and the students
in her Lyme Disease Research Group looks promising.
In a paper published in the European Journal of Microbiology & Immunology, Sapi and her students found that the most antibiotic resistant form of Borrelia
burgdorferi, the bacteria that causes Lyme disease — called biofilm — actually increased
in mass with individual antibiotics.
But liquid, whole-leaf stevia extract — not the powdered varieties that people most
commonly use — reduced the biofilm mass by about 40 percent, they found.
WFSB 3 CT News
"Is it the one?" Sapi asked. "I don't know." But in confirmation test after confirmation
test, "that is the one that jumped out."
A small clinical trial based out of New York got underway just a few months ago, and researchers there are using stevia along
with antibiotics to try and treat Lyme disease, while others are taking the extract
I've got emails from people saying they're getting better, but again, we need to have
double-blind clinical trials before we say ‘yes'. Everybody is holding their breath
to see if it helps, and let's hope for it. That would be wonderful.